|
1
|
LeRoy EC, Black C, Fleischmajer R,
Jablonska S, Krieg T, Medsger TAJ Jr, Rowell N and Wollheim F:
Scleroderma (systemic sclerosis): Classification, subsets and
pathogenesis. J Rheumatol. 15:202–205. 1988.PubMed/NCBI
|
|
2
|
Folwaczny C, Voderholzer W, Riepl RL and
Schindlbeck N: Clinical aspects, pathophysiology, diagnosis and
therapy of gastrointestinal manifestations of progressive systemic
scleroderma. Z Gastroenterol. 34:497–508. 1996.(In German).
PubMed/NCBI
|
|
3
|
Szamosi S, Szekanecz Z and Szűcs G:
Gastrointestinal manifestations in Hungarian scleroderma patients.
Rheumatol Int. 26:1120–1124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meier FMP, Frommer KW, Dinser R, Walker
UA, Czirjak L, Denton CP, Allanore Y, Distler O, Riemekasten G,
Valentini G, et al EUSTAR Co-authors, : Update on the profile of
the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and
Research group database. Ann Rheum Dis. 71:1355–1360. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Conio M, Blanchi S, Lapertosa G, Ferraris
R, Sablich R, Marchi S, D'Onofrio V, Lacchin T, Iaquinto G, Missale
G, et al: Long-term endoscopic surveillance of patients with
Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A
prospective study. Am J Gastroenterol. 98:1931–1939. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hendel L, Svejgaard E, Walsøe I, Kieffer M
and Stenderup A: Esophageal candidosis in progressive systemic
sclerosis: Occurrence, significance, and treatment with
fluconazole. Scand J Gastroenterol. 23:1182–1186. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watson M, Hally RJ, McCue PA, Varga J and
Jiménez SA: Gastric antral vascular ectasia (watermelon stomach) in
patients with systemic sclerosis. Arthritis Rheum. 39:341–346.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marie I, Ducrotte P, Antonietti M, Herve S
and Levesque H: Watermelon stomach in systemic sclerosis: Its
incidence and management. Aliment Pharmacol Ther. 28:412–421. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Armstrong D, Bennett JR, Blum AL, Dent J,
De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE,
Spechler SJ, et al: The endoscopic assessment of esophagitis: A
progress report on observer agreement. Gastroenterology. 111:85–92.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pech O: Esophageal Candidiasis. Video J
Encycl GI Endosc. 1:64–65. 2013. View Article : Google Scholar
|
|
11
|
Weusten B, Bisschops R, Coron E,
Dinis-Ribeiro M, Dumonceau JM, Esteban JM, Hassan C, Pech O, Repici
A, Bergman J, et al: Endoscopic management of Barrett's esophagus:
European Society of Gastrointestinal Endoscopy (ESGE) Position
Statement. Endoscopy. 49:191–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kaminishi M, Yamaguchi H, Nomura S, Oohara
T, Sakai S, Fukutomi H, Nakahara A, Kashimura H, Oda M, Kitahora T,
et al: Endoscopic classification of chronic gastritis based on the
results of a pilot study by research society for gastritis.
Gastroenterol Endosc. 45:1277–1291. 2003.
|
|
13
|
Akesson A and Wollheim FA: Organ
manifestations in 100 patients with progressive systemic sclerosis:
A comparison between the CREST syndrome and diffuse scleroderma. Br
J Rheumatol. 28:281–286. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thonhofer R, Siegel C, Trummer M and
Graninger W: Early endoscopy in systemic sclerosis without
gastrointestinal symptoms. Rheumatol Int. 32:165–168. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jaovisidha K, Csuka ME, Almagro UA and
Soergel KH: Severe gastrointestinal involvement in systemic
sclerosis: Report of five cases and review of the literature. Semin
Arthritis Rheum. 34:689–702. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steen VD and Medsger TAJ Jr: Severe organ
involvement in systemic sclerosis with diffuse scleroderma.
Arthritis Rheum. 43:2437–2444. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lahcene M, Oumnia N, Matougui N, Boudjella
M, Tebaibia A and Touchene B: Esophageal involvement in
scleroderma: Clinical, endoscopic, and manometric features. ISRN
Rheumatol. 2011:3258262011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wielosz E, Borys O, Zychowska I and Majdan
M: Gastrointestinal involvement in patients with systemic
sclerosis. Pol Arch Med Wewn. 120:132–136. 2010.PubMed/NCBI
|
|
19
|
Marie I, Ducrotte P, Denis P, Hellot MF
and Levesque H: Oesophageal mucosal involvement in patients with
systemic sclerosis receiving proton pump inhibitor therapy. Aliment
Pharmacol Ther. 24:1593–1601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bassotti G, Battaglia E, Debernardi V,
Germani U, Quiriconi F, Dughera L, Buonafede G, Puiatti P, Morelli
A, Spinozzi F, et al: Esophageal dysfunction in scleroderma:
Relationship with disease subsets. Arthritis Rheum. 40:2252–2259.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zuber-Jerger I, Müller A, Kullmann F,
Gelbmann CM, Endlicher E, Müller-Ladner U and Fleck M:
Gastrointestinal manifestation of systemic sclerosis - thickening
of the upper gastrointestinal wall detected by endoscopic
ultrasound is a valid sign. Rheumatology (Oxford). 49:368–372.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wielosz E, Borys O, Żychowska I and Majdan
M: Gastrointestinal involvement in patients with systemic
sclerosis. Pol Arch Med Wewn. 120:132–136. 2010.PubMed/NCBI
|
|
23
|
Petersen H, Johannessen T, Sandvik AK,
Kleveland PM, Brenna E, Waldum H and Dybdahl JD: Relationship
between endoscopic hiatus hernia and gastroesophageal reflux
symptoms. Scand J Gastroenterol. 26:921–926. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cameron AJ: Barrett's esophagus:
Prevalence and size of hiatal hernia. Am J Gastroenterol.
94:2054–2059. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weston AP, Badr AS and Hassanein RS:
Prospective multivariate analysis of clinical, endoscopic, and
histological factors predictive of the development of Barrett's
multifocal high-grade dysplasia or adenocarcinoma. Am J
Gastroenterol. 94:3413–3419. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wipff J, Coriat R, Masciocchi M,
Caramaschi P, Derk CT, Hachulla E, Riccieri V, Mouthon L, Krasowska
D, Ananyeva LP, et al: Outcomes of Barrett's oesophagus related to
systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research
prospective follow-up study. Rheumatology. 50:1440–1444. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Marie I, Dominique S, Levesque H, Ducrotté
P, Denis P, Hellot MF and Courtois H: Esophageal involvement and
pulmonary manifestations in systemic sclerosis. Arthritis Rheum.
45:346–354. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Recht MP, Levine MS, Katzka DA, Reynolds
JC and Saul SH: Barrett's esophagus in scleroderma: Increased
prevalence and radiographic findings. Gastrointest Radiol. 13:1–5.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gashi Z, Bahtiri E, Gashi A and Sherifi F:
Proton Pump Inhibitors Diminish Barrett's Esophagus Length: Our
Experience. Open Access Maced J Med Sci. 6:1041–1045. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Amital H, Govoni M, Maya R, Meroni PL, Ori
B, Shoenfeld Y, Tincani A, Trotta F, Sarzi-Puttini P and Atzeni F:
Role of infectious agents in systemic rheumatic diseases. Clin Exp
Rheumatol. 26 (Suppl 48):S27–S32. 2008.PubMed/NCBI
|
|
31
|
Radić M: Role of Helicobacter
pylori infection in autoimmune systemic rheumatic diseases.
World J Gastroenterol. 20:12839–12846. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Radić M, Kaliterna DM and Radić J:
Helicobacter pylori infection and systemic sclerosis - is
there a link? Joint Bone Spine. 78:337–340. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hooi JKY, Lai WY, Ng WK, Suen MMY,
Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu
JCY, et al: Global prevalence of Helicobacter pylori
infection: Systematic Review and Meta-Analysis. Gastroenterology.
153:420–429. 2017. View Article : Google Scholar : PubMed/NCBI
|
